Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in Previously Treated Malignant Mesothelioma
NCT00794859Phase 2Unknown
- Sponsor
- King's College London
- Start
- Oct 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in malignant mesothelioma, sponsored by King's College London. Status: unknown.
02
Drugs
sorafenib
03
Conditions
malignant mesothelioma
Beyond the preview
Go deeper on NCT00794859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00794859.